Medical Device News Magazine

New Exactech Knee Research Demonstrates Ability to Achieve Balanced Results with Short Learning Curve Using Newton™ Technology

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced a new study published in the Journal of Arthroplasty that showcases the ability of the Newton™ knee balancing technology to execute dynamic joint balance with a short learning curve. This is promising research for knee surgeons, who are interested in a full-range soft tissue management solution that provides real-time, personalized patient data without any associated capital investment.

The new study, which reviewed the first 273 surgeries using Exactech’s Newton Knee balancing system, demonstrated the ability for surgeons to achieve targeted gap balance throughout each patient’s range of motion. Combined with ExactechGPS®, the Newton technology allowed surgeons to create a surgical plan based on real-time soft tissue data and validate the achieved gap balance once the plan was executed. The research assessed learning curves associated with the adoption of the streamlined tibia-first gap balancing protocol and found them to be minimal.

“The Newton Knee surgical protocol offers surgeons a streamlined approach to achieve soft tissue balance throughout the entire arc of motion regardless of prior experience or training,” said James Huddleston, MD, Professor of Orthopaedic Surgery and Division Director, Adult Reconstruction Service at Stanford Healthcare. “Our initial findings demonstrate the utility and reliability of using Newton to plan and execute a patient-specific total knee replacement based on real-time intraoperative data.”

Used in more than 1,000 cases, Newton offers dynamic soft tissue analytics, predictive pre-resection operative insight, and full-range personalized planning designed to help simplify, evaluate and execute reproducible balanced total knee replacement surgery.

“Exactech is redefining soft tissue management through technology and innovation, and this new research demonstrates the value and benefit of our advanced approach,” said Adam Hayden, Exactech Chief Marketing Officer and Senior Vice President of Large Joints. “Newton opens up a world of opportunities with patient-driven insights that are designed to improve total knee replacement balancing and outcomes.”

Newton, along with GPS and many other smart solutions, comprise Active Intelligence®, Exactech’s enabling technology ecosystem that supports orthopaedic surgeons in and out of the operating room. For more information, visit www.NewtonKnee.com.

James Huddleston, MD, is a paid surgeon consultant of Exactech.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”